Innovent Biologics (HK:1801) has released an update.
Innovent Biologics, Inc. has successfully passed all proposed resolutions in its recent Extraordinary General Meeting (EGM), including the conditional grant of restricted shares to key executives as part of the company’s 2020 Restricted Share Plan. Shareholders voted in favor of these grants, showing strong support for the executive team, with votes for approval ranging from approximately 69% to almost 75% for different grants.
For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.
